Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma
FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling access to accelerated and rolling review FDA clearance of IND application enables initiation of…
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Press release – No. 7 / 2026 Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations Bringing significant experience from Vertex Pharmaceuticals and Shire Copenhagen, Denmark and Boston…
Nxera Pharma's QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Nxera's partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026 QUVIVIQ is approved through Taiwan's Streamlined Review Designation pathway…
Hormuz crisis may push up drug prices: Pharma MSMEs battle cost spike of raw materials, packaging
Disruptions in shipping routes have sharply raised input costs and triggered supply uncertainties for India's small-scale pharmaceutical manufacturers, who warn of cascading effects on medicine prices, availability and even quality. Several key…
Athira Pharma (NASDAQ:LONA) Shares Down 6.5% - Should You Sell?
Shares of Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) traded down 6.5% during mid-day trading on Tuesday. The company traded as low as $9.06 and last traded at $9.07. 35,461 shares traded hands during trading, a decline of 51% from the…
Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 9.3% - Here's What Happened
Innate Pharma SA (OTCMKTS:IPHYF - Get Free Report)'s stock price rose 9.3% during trading on Tuesday. The stock traded as high as $1.50 and last traded at $1.50. Approximately 1,000 shares traded hands during mid-day trading, an increase of 19,900%…
Cough drops sold nationwide recalled over undisclosed 'quality issues
READ MORE: More than 350,000 vitamins and supplements recalled More than a dozen types of cough drops have been urgently recalled due to undisclosed 'quality issues.' China-based firm Xiamen Kang Zhongyuan Biotechnology Co., Ltd., voluntarily…
Opinion | Dr. Makary and Mr. Hyde at the FDA
Food and Drug Administration biologics chief Vinay Prasad is stepping down at the end of this month after torpedoing breakthrough rare disease treatments. The grim reaper can't leave soon enough, but he's not leaving without kicking patients with…
Post-communist Cuba will need an export-led recovery
The slow-motion implosion of the Cuban economy is accelerating. While Venezuela has provided Cuba with heavily subsidized (practically free) oil, the removal of Nicolas Maduro as president combined with Russia's reluctance to contribute substantial…
Disability rights group condemns Graham Platner's use of 'retarded' in interview
Our political journalists are based in the Maine State House and have deep source networks across the partisan spectrum in communities all over the state. Their coverage aims to cut through major debates and probe how officials make decisions. Read…
Is the Nifty Party Over? Goldman Sachs Cuts Year-End Target by 14% as $100 Oil Hits Earnings
The revision comes as Goldman Sachs cut its 2026 earnings growth forecast for India from 16% to just 8%. While the recent surge in crude oil to over $100 per barrel acted as a catalyst, market analysts suggest the 'India story' was already under…
Becton Dickinson (BDX) Q4 2024 Earnings Transcript
Thursday, November 7, 2024 at 8 a.m. ET Chairman, Chief Executive Officer, and President — Tom Polen Executive Vice President and Chief Financial Officer — Chris DelOrefice President, Medical Segment — Mike Garrison President…
Helical raises $10M to bridge the gap between foundation models and drug discovery decisions
Pharma artificial intelligence startup Helical Ltd. announced today that it has raised $10 million in new funding to expand its virtual AI lab platform, which turns biological foundation models into reproducible in-silico drug discovery workflows.
Swiss continues to suspend flights to Dubai
Inside Geneva: can the UN survive? Read more: Inside Geneva: can the UN survive? Switzerland's Zug becomes bolt-hole for Gulf-based wealth Read more: Switzerland's Zug becomes bolt-hole for Gulf-based wealth Swiss entrepreneurs are staying put in…
Patient Capital Management Q1 2026 Portfolio Activity & Attribution
During the first quarter of 2026, the Patient Opportunity Equity Strategy generated a total return of -5.96% net of fees. In comparison, the Strategy's unmanaged benchmark, the S&P 500 Index (SPX), returned -4.33%.Using a three-factor performance…
Receive a Daily briefing on Pharma Industry News
Get Started